These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10560805)

  • 1. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
    Fischer KG; van de Loo A; Böhler J
    Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
    Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
    Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
    Dager WE; White RH
    Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II).
    Schneider T; Heuer B; Deller A; Boesken WH
    Wien Klin Wochenschr; 2000 Jun; 112(12):552-5. PubMed ID: 10953874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report.
    Whelen S; Carr ME
    Angiology; 2001 Oct; 52(10):711-5. PubMed ID: 11666136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
    Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
    Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
    Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
    J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirudin in renal insufficiency.
    Fischer KG
    Semin Thromb Hemost; 2002 Oct; 28(5):467-82. PubMed ID: 12420243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.
    Greinacher A; Janssens U; Berg G; Böck M; Kwasny H; Kemkes-Matthes B; Eichler P; Völpel H; Pötzsch B; Luz M
    Circulation; 1999 Aug; 100(6):587-93. PubMed ID: 10441094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy.
    Vargas Hein O; von Heymann C; Lipps M; Ziemer S; Ronco C; Neumayer HH; Morgera S; Welte M; Kox WJ; Spies C
    Intensive Care Med; 2001 Apr; 27(4):673-9. PubMed ID: 11403068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hirudin overdosage in a dialysis patient with heparin-induced thrombocytopenia with mixed hemodialysis and hemofiltration treatment.
    Mon C; Moreno G; Ortiz M; Diaz R; Herrero JC; Oliet A; Rodriguez I; Ortega O; Gallar P; Vigil A
    Clin Nephrol; 2006 Oct; 66(4):302-5. PubMed ID: 17063999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.
    Tsu LV; Dager WE
    Ann Pharmacother; 2011 Oct; 45(10):1185-92. PubMed ID: 21881032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
    Dager WE; Gosselin RC; Yoshikawa R; Owings JT
    Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.
    Kiser TH; Fish DN
    Pharmacotherapy; 2006 Apr; 26(4):452-60. PubMed ID: 16553502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent hirudin versus continuous heparin for anticoagulation in continuous renal replacement therapy.
    Hein OV; von Heymann C; Diehl T; Ziemer S; Ronco C; Morgera S; Siebert G; Kox WJ; Neumayer HH; Spies C
    Ren Fail; 2004 May; 26(3):297-303. PubMed ID: 15354980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
    Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
    Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.